T Cell News and Research

Latest T Cell News and Research

Study offers a combination treatment option for patients with oligometastatic prostate cancer

Study offers a combination treatment option for patients with oligometastatic prostate cancer

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

The impact of existing and theoretical mutations on SARS-CoV-2 CD8+ T cell targets

The impact of existing and theoretical mutations on SARS-CoV-2 CD8+ T cell targets

Researchers streamline way to manufacture CAR T-cells in just 24 hours

Researchers streamline way to manufacture CAR T-cells in just 24 hours

Immune response in SARS-CoV-1 survivors after COVID-19 vaccination

Immune response in SARS-CoV-1 survivors after COVID-19 vaccination

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

Impaired SARS-CoV-2 neutralization after booster vaccination in the elderly

What is the function of micronutrients in COVID-19 recovery?

What is the function of micronutrients in COVID-19 recovery?

Bioinformatics analysis of monkeypox virus-host cell interactions

Bioinformatics analysis of monkeypox virus-host cell interactions

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

Immune-mediated inflammatory diseases following COVID-19

Immune-mediated inflammatory diseases following COVID-19

The role of oxidative stress in congenital syndromes

The role of oxidative stress in congenital syndromes

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Omicron reduces host antibody response by lower B-cell antigenicity

Omicron reduces host antibody response by lower B-cell antigenicity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.